{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:38:52Z","timestamp":1793997532510,"version":"4.8.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019370","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018FY100900"],"award-info":[{"award-number":["2018FY100900"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018FY10090004"],"award-info":[{"award-number":["2018FY10090004"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ30915"],"award-info":[{"award-number":["2021JJ30915"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113395","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T05:43:02Z","timestamp":1657518182000},"page":"113395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["CD38: An important regulator of T cell function"],"prefix":"10.1016","volume":"153","author":[{"given":"Wentao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113395_bib1","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1002\/eji.1830231245","article-title":"The lymphocyte surface antigen CD38 acts as a nicotinamide adenine dinucleotide glycohydrolase in human T lymphocytes","volume":"23","author":"Gelman","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib2","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.159.8.3858","volume":"159","author":"Ferrero","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V92.4.1324","article-title":"Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses","volume":"92","author":"Cockayne","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib4","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1152\/physrev.00046.2020","article-title":"CD38 in the age of COVID-19: a medical perspective","volume":"101","author":"Horenstein","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2022.113395_bib5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/eji.1830250554","article-title":"CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes","volume":"25","author":"Ausiello","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib6","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26246","article-title":"A CD38\/CD203a\/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes","volume":"2","author":"Horenstein","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2022.113395_bib7","doi-asserted-by":"crossref","first-page":"6630295","DOI":"10.1155\/2021\/6630295","article-title":"CD38 and regulation of the immune response cells in cancer","volume":"2021","author":"Dwivedi","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2022.113395_bib8","first-page":"9","article-title":"The roles of CD38 and CD157 in the solid tumor microenvironment and cancer immunotherapy","author":"Wo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113395_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","article-title":"Metabolic regulation of T cell longevity and function in tumor immunotherapy","volume":"26","author":"Kishton","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113395_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38-Mediated Immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade","volume":"8","author":"Chen","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2022.113395_bib11","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.176.8.4590","article-title":"Targeted disruption of CD38 accelerates autoimmune diabetes in NOD\/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion","volume":"176","author":"Chen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib13","first-page":"146","article-title":"CD38 in T- and B-cell functions","volume":"75","author":"Deterre","year":"2000","journal-title":"Chem. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0092-8674(81)90441-4","article-title":"Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10","volume":"23","author":"Terhorst","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113395_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/eji.200324728","article-title":"CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction","volume":"34","author":"Fedele","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib16","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1902\/jop.2005.76.11.1960","article-title":"CD38 expression in neutrophils from patients with localized aggressive periodontitis","volume":"76","author":"Fujita","year":"2005","journal-title":"J. Periodontol."},{"key":"10.1016\/j.biopha.2022.113395_bib17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3389\/fimmu.2018.01593","article-title":"CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions","volume":"9","author":"Amici","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80353-2","article-title":"The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer","volume":"7","author":"Shubinsky","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113395_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tips.2018.02.001","article-title":"The pharmacology of CD38\/NADase: an emerging target in cancer and diseases of aging","volume":"39","author":"Chini","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2022.113395_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","article-title":"CD38 antibodies in multiple myeloma: back to the future","volume":"131","author":"van de Donk","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib21","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood-2007-07-101600","article-title":"Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse","volume":"111","author":"Munoz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib22","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1073\/pnas.1703718114","article-title":"Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels","volume":"114","author":"Liu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113395_bib23","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3892\/or.2014.3537","article-title":"CD38 is highly expressed and affects the PI3K\/Akt signaling pathway in cervical cancer","volume":"32","author":"Liao","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113395_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/neuonc\/nos121","article-title":"CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia\/macrophages","volume":"14","author":"Levy","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2022.113395_bib25","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-14-3639","article-title":"CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer","volume":"75","author":"Karakasheva","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113395_bib26","doi-asserted-by":"crossref","first-page":"31797","DOI":"10.18632\/oncotarget.25737","article-title":"Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis","volume":"9","author":"Ben Baruch","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113395_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/carcin\/bgx137","article-title":"CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells","volume":"39","author":"Bu","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2022.113395_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imr.12389","article-title":"Monoclonal antibodies targeting CD38 in hematological malignancies and beyond","volume":"270","author":"van de Donk","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2022.113395_bib29","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib30","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1021\/ja411046j","article-title":"Revealing CD38 cellular localization using a cell permeable, mechanism-based fluorescent small-molecule probe","volume":"136","author":"Shrimp","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2022.113395_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2022.113395_bib32","doi-asserted-by":"crossref","first-page":"27637","DOI":"10.1074\/jbc.M109.031005","article-title":"Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113395_bib33","doi-asserted-by":"crossref","first-page":"31633","DOI":"10.1074\/jbc.R112.349464","article-title":"Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113395_bib34","doi-asserted-by":"crossref","first-page":"28555","DOI":"10.1016\/S0021-9258(19)61940-X","article-title":"Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38","volume":"269","author":"Tohgo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113395_bib35","doi-asserted-by":"crossref","first-page":"ra67","DOI":"10.1126\/scisignal.2002700","article-title":"The membrane-bound enzyme CD38 exists in two opposing orientations","volume":"5","author":"Zhao","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biopha.2022.113395_bib36","first-page":"13","article-title":"Investigation of the potential role of membrane CD38 in protection against cell death induced by HIV-1","volume":"10","author":"Savarino","year":"1996","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2022.113395_bib37","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1096\/fasebj.13.15.2265","article-title":"Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle","volume":"13","author":"Savarino","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.113395_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/14728220802637147","article-title":"Evaluation of the antiretroviral effects of a PEG-conjugated peptide derived from human CD38","volume":"13","author":"Bensi","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2022.113395_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113395_bib40","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.4049\/jimmunol.156.9.3509","article-title":"Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression","volume":"156","author":"Gougeon","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib41","doi-asserted-by":"crossref","first-page":"10189","DOI":"10.1128\/JVI.02529-10","article-title":"HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo","volume":"85","author":"Meditz","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.113395_bib42","first-page":"85","article-title":"The CD8(+) T cell noncytotoxic antiviral responses","author":"Morvan","year":"2021","journal-title":"Microbiol Mol. Biol. Rev."},{"key":"10.1016\/j.biopha.2022.113395_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113395_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00002030-200006160-00004","article-title":"Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus\/host interactions?","volume":"14","author":"Savarino","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2022.113395_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1293.2007.00528.x","article-title":"CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy","volume":"9","author":"Steel","year":"2008","journal-title":"HIV Med."},{"key":"10.1016\/j.biopha.2022.113395_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.qai.0000153105.42455.c2","article-title":"Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy","volume":"38","author":"Benito","year":"2005","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.biopha.2022.113395_bib47","first-page":"1937","article-title":"CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals","volume":"22","author":"Kolber","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2022.113395_bib48","first-page":"36","article-title":"[The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV\/AIDS patients]","volume":"55","author":"Xie","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.biopha.2022.113395_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800128","article-title":"HIV disease progression: overexpression of the ectoenzyme CD38 as a contributory factor?","volume":"41","author":"Rodriguez-Alba","year":"2019","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2022.113395_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113395_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113395_bib52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113395_bib53","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","article-title":"Evolving concepts in NAD(+) metabolism","volume":"33","author":"Chini","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113395_bib54","first-page":"9","article-title":"CD38: T cell immuno-metabolic modulator","author":"Kar","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113395_bib55","first-page":"6","article-title":"Calcium-mediated shaping of naive CD4 T-cell phenotype and function","author":"Guichard","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2022.113395_bib56","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.113395_bib57","doi-asserted-by":"crossref","first-page":"25602","DOI":"10.18632\/oncotarget.4693","article-title":"A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation","volume":"6","author":"Morandi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113395_bib58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.biopha.2022.113395_bib59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood-2018-07-863233","article-title":"Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice","volume":"133","author":"Daenthanasanmak","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113395_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2018.02.001","article-title":"Abnormal acetylation of FOXP3 regulated by SIRT-1 induces Treg functional deficiency in patients with abdominal aortic aneurysms","volume":"271","author":"Jiang","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2022.113395_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.10.006","article-title":"CD38-NAD(+)axis regulates immunotherapeutic anti-tumor T cell response","volume":"27","author":"Chatterjee","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113395_bib62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20132378","article-title":"SIRT1 deacetylates RORgammat and enhances Th17 cell generation","volume":"212","author":"Lim","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113395_bib63","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.celrep.2017.04.004","article-title":"Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation","volume":"19","author":"Limagne","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.113395_bib64","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Canto","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113395_bib65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41584-021-00629-8","article-title":"Linking NAD metabolism and DNA repair to inflammation in SSc","volume":"17","author":"Avvedimento","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113395_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/138161209787185788","article-title":"CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions","volume":"15","author":"Chini","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"112\u2013123","key":"10.1016\/j.biopha.2022.113395_bib67","article-title":"The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections","volume":"30","author":"Katsuyama","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.113395_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.it.2020.01.008","article-title":"CD38: modulating histone methyltransferase EZH2 activity in SLE","volume":"41","author":"Chakraborty","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib69","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.4049\/jimmunol.174.6.3298","article-title":"CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins","volume":"174","author":"Krebs","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib70","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.165.8.4463","article-title":"Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation","volume":"165","author":"Kahl","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib71","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1196\/annals.1299.051","article-title":"Triggering of T-cell apoptosis by toxin-related ecto-ADP-ribosyltransferase ART2","volume":"1010","author":"Scheuplein","year":"2003","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2022.113395_bib72","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/MCB.22.21.7535-7542.2002","article-title":"Generation and characterization of ecto-ADP-ribosyltransferase ART2.1\/ART2.2-deficient mice","volume":"22","author":"Ohlrogge","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113395_bib73","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.4049\/jimmunol.175.5.3075","article-title":"High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors","volume":"175","author":"Aswad","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib74","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1084\/jem.20091154","article-title":"Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway","volume":"207","author":"Hubert","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113395_bib75","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/MCB.01746-07","article-title":"Regulation of transcription factor NFAT by ADP-ribosylation","volume":"28","author":"Olabisi","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113395_bib76","article-title":"Pan-cancer analysis of PARP1 alterations as biomarkers in the prediction of immunotherapeutic effects and the association of its expression levels and immunotherapy signatures","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib77","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.4049\/jimmunol.176.12.7301","article-title":"Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes","volume":"176","author":"Thoren","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib78","article-title":"PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113395_bib79","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/etm.2020.9566","article-title":"Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17\/Treg cells and inhibiting the NF-kappaB signaling pathway","volume":"21","author":"Peng","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2022.113395_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153021","article-title":"PARP-1 inhibitor-AG14361 suppresses acute allograft rejection via stabilizing CD4+FoxP3+ regulatory T cells","volume":"216","author":"Gu","year":"2020","journal-title":"Pathol. Res Pract."},{"key":"10.1016\/j.biopha.2022.113395_bib81","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.0901568","article-title":"Increased Foxp3+ regulatory T cells in poly(ADP-Ribose) polymerase-1 deficiency","volume":"184","author":"Nasta","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib82","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1399-0012.2008.00815.x","article-title":"CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation","volume":"22","author":"Boleslawski","year":"2008","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.biopha.2022.113395_bib83","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbmt.2015.04.010","article-title":"Peripheral blood CD38 bright CD8+ effector memory T cells predict acute graft-versus-host disease","volume":"21","author":"Khandelwal","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.biopha.2022.113395_bib84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41385-018-0078-4","article-title":"Frequencies of circulating regulatory TIGIT(+)CD38(+) effector T cells correlate with the course of inflammatory bowel disease","volume":"12","author":"Joosse","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1086\/380793","article-title":"CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy","volume":"38","author":"Resino","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113395_bib86","first-page":"458","article-title":"Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study","volume":"115","author":"Burgisser","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib87","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hon.877","article-title":"T-cell CD38 expression in B-chronic lymphocytic leukaemia","volume":"27","author":"Abousamra","year":"2009","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.biopha.2022.113395_bib88","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/CBM-190946","article-title":"High CD38 expression in childhood T-cell acute lymphoblastic leukemia is not associated with prognosis","volume":"27","author":"Liao","year":"2020","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.biopha.2022.113395_bib89","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2022.113395_bib90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00262-017-1990-2","article-title":"The multi-faceted potential of CD38 antibody targeting in multiple myeloma","volume":"66","author":"Shallis","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2022.113395_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2018.04.005","article-title":"Immunomodulatory effects of CD38-targeting antibodies","volume":"199","author":"van de Donk","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2022.113395_bib92","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3389\/fimmu.2018.02134","article-title":"CD38 antibodies in multiple myeloma: mechanisms of action and modes of resistance","volume":"9","author":"van de Donk","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113395_bib93","first-page":"12","article-title":"Preclinical rationale for targeting the PD-1\/PD-L1 axis in combination with a CD38 antibody in multiple myeloma and other CD38-positive malignancies","author":"Verkleij","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2022.113395_bib94","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/13543784.2020.1814253","article-title":"CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers","volume":"29","author":"Jiao","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"65\u201370","key":"10.1016\/j.biopha.2022.113395_bib95","article-title":"The link between bone microenvironment and immune cells in multiple myeloma: emerging role of CD38","volume":"205","author":"Bolzoni","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2022.113395_bib96","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/bloodadvances.2019001091","article-title":"Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses","volume":"4","author":"Manna","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2022.113395_bib97","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jgg.2019.06.007","article-title":"Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells","volume":"46","author":"Gao","year":"2019","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.biopha.2022.113395_bib98","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/CJI.0b013e3181adaff1","article-title":"Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma","volume":"32","author":"Mihara","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.biopha.2022.113395_bib99","doi-asserted-by":"crossref","first-page":"4241864","DOI":"10.1155\/2020\/4241864","article-title":"Application of chimeric antigen receptor T cells in the treatment of hematological malignancies","volume":"2020","author":"Yan","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2022.113395_bib100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","article-title":"The application of CAR-T cell therapy in hematological malignancies: advantages and challenges","volume":"8","author":"Zhao","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113395_bib101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"\u2018Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2022.113395_bib102","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/acs.molpharmaceut.8b00584","article-title":"Anti-multiple myeloma activity of nanobody-based anti-CD38 chimeric antigen receptor T cells","volume":"15","author":"An","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2022.113395_bib103","first-page":"22","article-title":"Preclinical evaluation of invariant natural killer T cells modified with CD38 or BCMA chimeric antigen receptors for multiple myeloma","author":"Poels","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113395_bib104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2010.08297.x","article-title":"Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma","volume":"151","author":"Mihara","year":"2010","journal-title":"Br. J. Haematol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222007843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222007843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:22:18Z","timestamp":1779967338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222007843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":104,"alternative-id":["S0753332222007843"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113395","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD38: An important regulator of T cell function","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113395"}}